Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

3
results for

"Dongho Choi"

Article category

Keywords

Publication year

"Dongho Choi"

Review

Artificial intelligence, epidemiology, methodology, or others

Liver organoids: Current advances and future applications for hepatology
Yohan Kim, Minseok Kang, Michael Girma Mamo, Michael Adisasmita, Meritxell Huch, Dongho Choi
Clin Mol Hepatol 2025;31(Suppl):S327-S348.
Published online December 26, 2024
DOI: https://doi.org/10.3350/cmh.2024.1040
The creation of self-organizing liver organoids represents a significant, although modest, step toward addressing the ongoing organ shortage crisis in allogeneic liver transplantation. However, researchers have recognized that achieving a fully functional whole liver remains a distant goal, and the original ambition of organoid-based liver generation has been temporarily put on hold. Instead, liver organoids have revolutionized the field of hepatology, extending their influence into various domains of precision and molecular medicine. These 3D cultures, capable of replicating key features of human liver function and pathology, have opened new avenues for human-relevant disease modeling, CRISPR gene editing, and high-throughput drug screening that animal models cannot accomplish. Moreover, advancements in creating more complex systems have led to the development of multicellular assembloids, dynamic organoid-on-chip systems, and 3D bioprinting technologies. These innovations enable detailed modeling of liver microenvironments and complex tissue interactions. Progress in regenerative medicine and transplantation applications continues to evolve and strives to overcome the obstacles of biocompatibility and tumorigenecity. In this review, we examine the current state of liver organoid research by offering insights into where the field currently stands, and the pivotal developments that are shaping its future.

Citations

Citations to this article as recorded by  Crossref logo
  • NSD2 exacerbates metabolic dysfunction-associated steatotic liver disease progression by suppressing TFEB-mediated autophagy-lysosomal pathway
    Yuan Qiao, Yijia Zhang, Cuiting Sun, Qi Jin, Peng Qu, Zecheng Li, Yang Qiu, Hua Meng, Dantao Peng, Liang Peng
    Metabolism.2026; 174: 156416.     CrossRef
  • Liver Organoid and Liver‐On‐A‐Chip Platforms for Modeling Alcoholic Liver Disease: A Comparative Review
    Qiannan Chen, Chengpan Li, Weiping Ding, Derun Kong
    Advanced Healthcare Materials.2026;[Epub]     CrossRef
  • Engineering liver organoids-on-a-chip
    Jiafei Zhu, Anna Dressman, Kylee Gall, Sunghee Estelle Park
    Frontiers in Lab on a Chip Technologies.2026;[Epub]     CrossRef
  • From initiation to maturation: Mesenchymal stem cells as key facilitators in organoid development
    Shihao Yi, Juan Wen, Tianshun Wang, Wan Yu, Yanlin Liao, Zhengyun Liu, Huan Wang
    Cells & Development.2026; 185: 204071.     CrossRef
  • Transcriptomic Profile of Directed Differentiation of iPSCs into Hepatocyte-like Cells
    Irina Panchuk, Valeriia Kovalskaia, Konstantin Kochergin-Nikitsky, Valentina Yakushina, Natalia Balinova, Oxana Ryzhkova, Alexander Lavrov, Svetlana Smirnikhina
    International Journal of Molecular Sciences.2026; 27(2): 633.     CrossRef
  • Gene Editing of Pluripotent Stem Cell-Derived Hepatic Cells for Liver Disease Modeling and Therapeutic Development
    Donghyun Lim, Hyung-Ryong Kim
    Biomolecules & Therapeutics.2026; 34(1): 102.     CrossRef
  • Advancements, Strategies, and Challenges in Organoid-Based Drug Evaluation for Tissue Engineering and Regenerative Medicine
    Chengbin Xue, Fujia Sun, Hui Zhu, Jianfeng Shi, Jiaqi Wang, Qiuwen Sun, Muyuan Tong, Xiaosong Gu, Qianqian Han, Wei Shi
    Engineering.2025;[Epub]     CrossRef
  • Immunosenescence and organoids: pathophysiology and therapeutic opportunities
    Amirhossein Kamroo, Mahsa Hosseini Kakroudi, Amirreza Jabbaripour Sarmadian, Ayda Firouzabadi, Shaghayegh Mousavi, Niloufar Yazdanpanah, Kiarash Saleki, Nima Rezaei
    Immunity & Ageing.2025;[Epub]     CrossRef
  • Single-cell sequencing and organoids: applications in organ development and disease
    Tiantian Li, Jianmei Yin, Yang Hao, Wei Gao, Qirong Li, Qiang Feng, Boqiang Tao, Ming Hao, Yanxin Liu, Chao Lin, Dongxu Wang
    Molecular Biomedicine.2025;[Epub]     CrossRef
  • Liver Innervation in Health and Disease: Neuroimmune–Neurovascular Interface and Future Therapeutic Implications
    Marcello Trucas, Denis Barry, Melissa J. Conroy, Michela Vincis, Andrea Diana, Claudio Intini, Pietro Gobbi, Clara Gerosa, Daniela Fanni, Andrea Perra
    Biomedicines.2025; 13(12): 3091.     CrossRef
  • Advanced Machine-Assisted Liver Reconditioning in Critical Care
    Yaroslava Longhitano, Giorgia Caputo, Michela Colella Bisogno, Cristian Manuel Perez, Raymond Planinsic, Sabino Mosca, Roberto Balagna, Gabriele Savioli, Christian Zanza
    Journal of Intensive Care Medicine.2025;[Epub]     CrossRef
  • 10,229 View
  • 439 Download
  • 11 Web of Science
  • Crossref

Original Article

Liver Transplantation

Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry
Jong Man Kim, Deok Gie Kim, Jihyun Kim, Keunsung Lee, Kwang-Woong Lee, Je Ho Ryu, Bong-Wan Kim, Dong Lak Choi, Young Kyoung You, Dong-Sik Kim, Yang Won Nah, Koo Jeong Kang, Jai Young Cho, Geun Hong, Hee Chul Yu, Ju Ik Moon, Dongho Choi, Shin Hwang, Myoung Soo Kim
Clin Mol Hepatol 2021;27(3):451-462.
Published online February 2, 2021
DOI: https://doi.org/10.3350/cmh.2020.0292
Background/Aims
To analyze the incidence and risk factors of outcomes after liver transplantation (LT) in the Korean population.
Methods
This study analyzed data from the liver cohort of Korean Organ Transplantation Registry (KOTRY) who had LT between May 2014 and December 2017. Study measures included the incidence of post-LT outcomes in recipients of living donor LT (LDLT) and deceased donor LT (DDLT). Cox multivariate proportional hazards model was used to determine the potential risk factors predicting the outcomes.
Result
s: A total of 2,563 adult recipients with LT (LDLT, n=1,956; DDLT, n=607) were included, with mean±standard deviation age of 53.9±8.9 years, and 72.2% were male. The post-LT outcomes observed in each LDLT and DDLT recipients were death (4.0% and 14.7%), graft loss (5.0% and 16.1%), rejection (7.0% and 12.0%), renal failure (2.7% and 13.8%), new onset of diabetes (12.5% and 15.4%), and hepatocellular carcinoma (HCC) recurrence (both 6.7%). In both LDLT and DDLT recipients, the most common post-LT complications were renal dysfunction (33.6% and 51.4%), infection (26.7% and 48.4%), and surgical complication (22.5% and 23.9%). Incidence of these outcomes were generally higher among recipients of DDLT than LDLT. Multivariate analysis indicated recipient age and DDLT as significant risk factors associated with death and graft loss. DDLT and ABO incompatible transplant were prognostic factors for rejection, and HCC beyond Milan criteria at pre-transplant was a strong predictor of HCC recurrence.
Conclusions
This study is a good indicator of the post-LT prognosis in the Korean population and suggests a significant burden of post-LT complications.

Citations

Citations to this article as recorded by  Crossref logo
  • Outcomes of living-donor liver transplantation in older patients over 65 and 70 years compared to the younger recipients
    Deok-Gie Kim, Young Jin Yoo, Minyu Kang, Hwa-hee Koh, Eun-Ki Min, Jae Geun Lee, Myoung Soo Kim, Dong Jin Joo
    Asian Journal of Surgery.2026; 49(1): 76.     CrossRef
  • Outcomes of Highly Urgent ABO-Incompatible Living Donor Liver Transplantation in National Databases
    Jongman Kim, Sang Jin Kim, Boram Park, Kyunga Kim, YoungRok Choi, Geun Hong, Jun Yong Park, Young Seok Han, Nam-Joon Yi, Seung Heui Hong, Soon-Young Kim, Jungbun Park, Youngwon Hwang, Dong-Hwan Jung
    Journal of Korean Medical Science.2026;[Epub]     CrossRef
  • Temporal evolution of living donor liver transplantation survival—A United Network for Organ Sharing registry study
    Christian T.J. Magyar, Zhihao Li, Laia Aceituno, Marco P.A.W. Claasen, Tommy Ivanics, Woo Jin Choi, Luckshi Rajendran, Blayne A. Sayed, Roxana Bucur, Nadia Rukavina, Nazia Selzner, Anand Ghanekar, Mark Cattral, Gonzalo Sapisochin
    American Journal of Transplantation.2025; 25(2): 406.     CrossRef
  • Impact of Chronic Hepatitis C Virus on Acute Kidney Injury After Living Donor Liver Transplantation
    Jae Hwan Kim, Kyoung-Sun Kim, Hye-Mee Kwon, Sung-Hoon Kim, In-Gu Jun, Jun-Gol Song, Gyu-Sam Hwang
    Anesthesia & Analgesia.2025; 141(3): 608.     CrossRef
  • Preoperative Factors Affecting Graft Survival After ABO-incompatible Adult Liver Transplantation
    Hyun-Jun Nam, Deok-Gie Kim, Eun-Ki Min, Jae Geun Lee, Dai Hoon Han, Sinyoung Kim, Kyung-A Lee, Gi Hong Choi, Dong Jin Joo, Hyun Ok Kim, Soon Sung Kwon, Myoung Soo Kim
    Transplantation.2025; 109(3): e157.     CrossRef
  • Association of primary hepatocellular carcinoma laterality with oncological outcomes for hepatic resection patients: A retrospective, multicenter, propensity score-matched study
    Okjoo Lee, Jaehong Jeong, So Kyung Yoon, Jun Chul Chung, Jongman Kim, Kwang-Woong Lee, Hyung Chul Kim
    Asian Journal of Surgery.2025; 48(4): 2241.     CrossRef
  • Intrapatient variability of tacrolimus trough level may be not the cause, but an indirect parameter of comorbidities: Editorial on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development foll
    Jongman Kim
    Clinical and Molecular Hepatology.2025; 31(2): 589.     CrossRef
  • Emergency living donor liver transplantation
    Jongman Kim
    Annals of Liver Transplantation.2025; 5(1): 27.     CrossRef
  • Safety and Therapeutic Outcomes of Adjuvant Immunotherapy With Autologous Cytokine-induced Killer Cells for Patients With Hepatocellular Carcinoma Beyond Milan Criteria After Liver Transplantation
    Geun Hong, Dong Kyu Han, Jinsoo Rhu, Suk Kyun Hong, YoungRok Choi, Nam-Joon Yi, Kwang-Woong Lee, Jongman Kim, Jaeseok Yang, Kyung-Suk Suh
    Transplantation.2025; 109(10): e596.     CrossRef
  • Meta‐Analysis: Comparison of Living Versus Deceased Liver Transplantation for Primary Sclerosing Cholangitis
    Ana Beatriz Afonso, Carolina Morais da Silva, Paulo Nogueira, Mariana Verdelho Machado
    Alimentary Pharmacology & Therapeutics.2025; 62(8): 768.     CrossRef
  • Integrating Alpha‐Fetoprotein and Protein Induced by Vitamin K Antagonist‐II as Surveillance Tools After Liver Transplantation for Hepatocellular Carcinoma: A Novel Protocol for Early Detection of Tumor Recurrence
    Jiyoung Kim, Kwang‐Woong Lee, Jae‐Yoon Kim, Jaewon Lee, Hyun Hwa Choi, Su young Hong, Jeong‐Moo Lee, Suk Kyun Hong, YoungRok Choi, Nam‐Joon Yi, Kyung‐Suk Suh
    Clinical Transplantation.2025;[Epub]     CrossRef
  • The evaluation of inflammatory and immune composite markers for complications after deceased donor liver transplantation – a retrospective cohort study
    Zhihong Zheng, Shuman Kuang, Zipei Wang, Jin Gu, Jichang Jiang, Zhou Yu, Lijin Zhao
    Annals of Medicine.2025;[Epub]     CrossRef
  • Machine Learning–Based Selection of Resection vs Transplant and Survival in Hepatocellular Carcinoma
    Hyun Uk Kim, Ji Won Han, Pil Soo Sung, Jeong Won Jang, Seung Kew Yoon, Ho Joong Choi, Young Kyoung You
    JAMA Network Open.2025; 8(9): e2532353.     CrossRef
  • Living versus deceased donor liver transplantation in highly urgent patients using Korean national data
    Jongman Kim, Sang Jin Kim, Kyunga Kim, YoungRok Choi, Geun Hong, Jun Yong Park, Young Seok Han, Nam-Joon Yi, Soon-Young Kim, Jung-Bun Park, Youngwon Hwang, Dong-Hwan Jung
    Annals of Liver Transplantation.2025; 5(2): 115.     CrossRef
  • Predicting risk factors for waiting mortality in adult emergent living donor liver transplantation based on Korean national data
    Sang Jin Kim, Jongman Kim, Kyunga Kim, Soon-Young Kim, Jung-Bun Park, Youngwon Hwang, Dong-Hwan Jung
    Annals of Liver Transplantation.2025; 5(2): 107.     CrossRef
  • Liver Transplantation for Hepatocellular Carcinoma: A Comprehensive Review
    Seok-Hwan Kim
    Convergence Hepatology.2025; 1(1): 24.     CrossRef
  • Causes of death and associated factors with death after liver transplantation: a nationwide database study
    Junghyun Yoon, Hanjoon Kim, Dongho Choi, Boyoung Park
    HPB.2024; 26(1): 54.     CrossRef
  • Clinical impact and risk factors for cytomegalovirus infection in deceased donor liver transplantation without prophylaxis: Single center experience
    Deok-Gie Kim, Eun-Ki Min, Jae Geun Lee, Dong Jin Joo, Myoung Soo Kim
    Annals of Liver Transplantation.2024; 4(1): 23.     CrossRef
  • Recurrence risk prediction models for hepatocellular carcinoma after liver transplantation
    Xu Zhang, Chi Chen, Yan Wang, Jun Xu
    Journal of Gastroenterology and Hepatology.2024; 39(11): 2272.     CrossRef
  • Chitinase-3 like-protein-1, a prognostic biomarker in patients with hepatocellular carcinoma and concomitant myosteatosis
    Chiyu He, Zhihang Hu, Zuyuan Lin, Hao Chen, Chenghao Cao, Jinyan Chen, Xudong Yang, Huigang Li, Wei Shen, Xuyong Wei, Li Zhuang, Shusen Zheng, Xiao Xu, Di Lu
    BMC Cancer.2024;[Epub]     CrossRef
  • Mortality and associated factors among patients who underwent liver transplantation in South Korea from 2017 to 2021: a retrospective observational study
    Tak Kyu Oh, In-Ae Song
    Annals of Surgical Treatment and Research.2024; 107(5): 245.     CrossRef
  • Effects of combined immunosuppressant and hepatitis B virus antiviral use on COVID-19 vaccination in recipients of living donor liver transplantation
    Ryunjin Lee, Jiwan Choi, Eunkyeong Lee, Jooyoung Lee, Jiye Kim, Seoon Kang, Hye-In An, Sung-Han Kim, Sung-Min Kim, Eun-Kyoung Jwa, Gil-Chun Park, Jung-Man Namgoong, Gi-Won Song, Young-In Yoon, Eunyoung Tak, Sung-Gyu Lee
    PeerJ.2024; 12: e18651.     CrossRef
  • Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study
    Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
    European Journal of Internal Medicine.2023; 107: 66.     CrossRef
  • Comparable Mortality Between Asian Patients with Chronic Hepatitis B Under Long-Term Antiviral Therapy vs Matched Control: A Population-Based Study
    Byungyoon Yun, Juyeon Oh, Sang Hoon Ahn, Jin-Ha Yoon, Beom Kyung Kim
    American Journal of Gastroenterology.2023; 118(6): 1001.     CrossRef
  • Physical Performance Decline During the Early Posttransplantation Period Affects Survival After Living Donor Liver Transplantation
    Deok-Gie Kim, Shin Hwang, Kwang-Woong Lee, Gyu-seong Choi, Young Kyoung You, Je Ho Ryu, Bong-Wan Kim, Yang Won Nah, Dong-Sik Kim, Jai Young Cho, Koo Jeong Kang, Geun Hong, Hee Chul Yu, Man ki Ju, Suk-Won Suh, Kwan Woo Kim, Dongho Choi, Jaehong Jeong, Soo
    Transplantation.2023; 107(7): 1545.     CrossRef
  • Validation of the Model for End-Stage Liver Disease 3.0 in Korean Patients on the Liver Transplant Waiting List
    Jiwon Yang, Jung-Bin Park, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Jonggi Choi
    Clinical Gastroenterology and Hepatology.2023; 21(13): 3437.     CrossRef
  • Incidence, mortality, and risk factors associated with carbapenem‐resistant Acinetobacter baumannii bacteremia within 30 days after liver transplantation
    Eun‐Ki Min, Seung Hyuk Yim, Mun Chae Choi, Jae Geun Lee, Dong Jin Joo, Myoung Soo Kim, Deok‐Gie Kim
    Clinical Transplantation.2023;[Epub]     CrossRef
  • Risk Factors for Cytomegalovirus Infection and Its Impact on Survival after Living Donor Liver Transplantation in South Korea: A Nested Case-Control Study
    Seung Hyuk Yim, Mun Chae Choi, Deok-Gie Kim, Eun-Ki Min, Jae Geun Lee, Dong Jin Joo, Myoung Soo Kim
    Pathogens.2023; 12(4): 521.     CrossRef
  • Impact of institutional case volume of solid organ transplantation on patient outcomes and implications for healthcare policy in Korea
    Christine Kang, Ho Geol Ryu
    Korean Journal of Transplantation.2023; 37(1): 1.     CrossRef
  • Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
    Beom Kyung Kim, Sang Hoon Ahn
    Journal of the Formosan Medical Association.2023; 122(12): 1238.     CrossRef
  • Living donor liver transplantation can address disparities in transplant access for patients with primary sclerosing cholangitis
    Fernanda Onofrio, Katina Zheng, Cherry Xu, Shiyi Chen, Wei Xu, Mary Vyas, Katie Bingham, Keyur Patel, Leslie Lilly, Mark Cattral, Nazia Selzner, Elmar Jaeckel, Cynthia Tsien, Aliya Gulamhusein, Gideon M. Hirschfield, Mamatha Bhat
    Hepatology Communications.2023;[Epub]     CrossRef
  • Cancer Incidence in Living Liver Donors After Donor Hepatectomy
    Jongman Kim, Jae Heon Kim, Hyun Jung Kim
    Journal of Korean Medical Science.2023;[Epub]     CrossRef
  • The Effect of Model for End-Stage Liver Disease 3.0 on Disparities between Patients with and without Hepatocellular Carcinoma in Korea
    Kunhee Kim, Deok-Gie Kim, Jae Geun Lee, Dong Jin Joo, Hye Won Lee
    Yonsei Medical Journal.2023; 64(11): 647.     CrossRef
  • Pretransplant Functional Status Predicts Postoperative Morbidity and Mortality after Liver Transplantation in Patients with Cirrhosis
    Myung Ji Goh, Jihye Kim, Won Hyuk Chang, Dong Hyun Sinn, Geum-Yeon Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Jong Man Kim, Wonseok Kang
    Gut and Liver.2023; 17(5): 786.     CrossRef
  • Successful liver transplantation from a donor with occlusive portal vein thrombosis
    M. S. Novruzbekov, O. D. Olisov, V. A. Gulyaev, K. N. Lutsyk, B. I. Yaremin, B. I. Kazymov, K. M. Magomedov, A. R. Akhmedov, K. F. Alekberov
    Transplantologiya. The Russian Journal of Transplantation.2023; 15(3): 334.     CrossRef
  • Evidence-based hyponatremia management in liver disease
    Ji Young Ryu, Seon Ha Baek, Sejoong Kim
    Clinical and Molecular Hepatology.2023; 29(4): 924.     CrossRef
  • Association between the early high level of serum tacrolimus and recurrence of hepatocellular carcinoma in ABO-incompatible liver transplantation
    Ji Won Han, Jong Young Choi, Eun Sun Jung, Ji Hoon Kim, Hee Sun Cho, Jae-Sung Yoo, Pil Soo Sung, Jeong Won Jang, Seung Kew Yoon, Ho Joong Choi, Young Kyoung You
    World Journal of Gastrointestinal Surgery.2023; 15(12): 2727.     CrossRef
  • Outcomes of living liver donors are worse than those of matched healthy controls
    Jin Yong Choi, Jae Heon Kim, Jong Man Kim, Hyun Jung Kim, Hyeong Sik Ahn, Jae-Won Joh
    Journal of Hepatology.2022; 76(3): 628.     CrossRef
  • Changes in the Deceased-Donor Trend in Korea: Establishment of Regional Trauma Centers and KODA
    Jeong-Moo Lee
    Journal of Clinical Medicine.2022; 11(5): 1239.     CrossRef
  • Healthy Spouses can be Considered as Living Liver Donors
    Okjoo Lee, Jong Man Kim, Sang Jin Kim, Jinsoo Rhu, Gyu‐Seong Choi, Jae‐Won Joh
    World Journal of Surgery.2022; 46(6): 1474.     CrossRef
  • De Novo Intrahepatic Cholangiocarcinoma After Deceased Donor Liver Transplant in an Adult Patient
    Hyung Hwan Moon, Dong Hoon Shin, Young Il Choi
    Experimental and Clinical Transplantation.2022; 20(3): 316.     CrossRef
  • Long-Term Outcomes of Laparoscopic Liver Resection for Centrally Located Hepatocellular Carcinoma
    Hyo Jun Kim, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Yeongsoo Jo, Meeyouong Kang, Yeshong Park, Eunhye Lee
    Medicina.2022; 58(6): 737.     CrossRef
  • Long-term Clinical Outcomes and Predictive Factors for Living-donor Liver Transplant Recipients With Biliary Strictures
    Ji Won Han, Jong Young Choi, Soon Kyu Lee, Pil Soo Sung, Jeong Won Jang, Seung Kew Yoon, Young Hoon Choi, In Seok Lee, Jung Suk Oh, Ho Jong Chun, Ho Joong Choi, Young Kyoung You
    Transplantation.2022; 106(10): 1990.     CrossRef
  • Non-Renal Risk Factors for Chronic Kidney Disease in Liver Recipients with Functionally Intact Kidneys at 1 Month
    Deok-Gie Kim, Shin Hwang, Jong Man Kim, Je Ho Ryu, Young Kyoung You, Donglak Choi, Bong-Wan Kim, Dong-Sik Kim, Yang Won Nah, Tae-Seok Kim, Jai Young Cho, Geun Hong, Jae Do Yang, Jaryung Han, Suk-Won Suh, Kwan Woo Kim, Yun Kyung Jung, Ju Ik Moon, Jun Young
    Journal of Clinical Medicine.2022; 11(14): 4203.     CrossRef
  • Evidence of nonsurgical treatment for polycystic liver disease
    Jeong-Ju Yoo, Hye In Jo, Eun-Ae Jung, Jae Seung Lee, Sang Gyune Kim, Young Seok Kim, Beom Kyung Kim
    Therapeutic Advances in Chronic Disease.2022;[Epub]     CrossRef
  • Real‐world clinical features, health‐care utilization, and economic burden in decompensated cirrhosis patients: A national database
    Hankil Lee, Beom Kyung Kim
    Journal of Gastroenterology and Hepatology.2022; 37(11): 2154.     CrossRef
  • Low-grade hepatocellular carcinoma characteristics, a practical nomogram and risk stratification system: a SEER population-based study
    Dashuai Yang, Yang Su, Fangrui Zhao, Yong Hu, Kailiang Zhao, Xiangyun Xiong, Mingqiang Zhu, Junpeng Pei, Youming Ding
    Expert Review of Gastroenterology & Hepatology.2022; 16(11-12): 1115.     CrossRef
  • Low utilization of adult-to-adult LDLT in Western countries despite excellent outcomes: International multicenter analysis of the US, the UK, and Canada
    Tommy Ivanics, David Wallace, Marco P.A.W. Claasen, Madhukar S. Patel, Rushin Brahmbhatt, Chaya Shwaartz, Andreas Prachalias, Parthi Srinivasan, Wayel Jassem, Nigel Heaton, Mark S. Cattral, Nazia Selzner, Anand Ghanekar, Gabriela Morgenshtern, Neil Mehta,
    Journal of Hepatology.2022; 77(6): 1607.     CrossRef
  • Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review
    Sang Jin Kim, Jong Man Kim
    Clinical and Molecular Hepatology.2022; 28(4): 739.     CrossRef
  • Development and Validation of a Difficulty Scoring System for Laparoscopic Liver Resection to Treat Hepatolithiasis
    Yeongsoo Jo, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Eunhye Lee, Yeshong Park, MeeYoung Kang, Junghyun Lee
    Medicina.2022; 58(12): 1847.     CrossRef
  • Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
    Jae Lee, Tae Lim, Hye Lee, Seung Kim, Jun Park, Do Kim, Sang Ahn, Hyun Lee, Jung Lee, Ja Kim, In Min, Beom Kim
    Diagnostics.2022; 13(1): 3.     CrossRef
  • New Evidence of Oral Branched-Chain Amino Acid Supplementation on the Prognosis of Patients With Advanced Liver Disease
    Hankil Lee, Jeong-Ju Yoo, Sang Hoon Ahn, Beom Kyung Kim
    Clinical and Translational Gastroenterology.2022; 13(12): e00542.     CrossRef
  • Extubation in the operating room results in fewer composite mechanical ventilation-related adverse outcomes in patients after liver transplantation: a retrospective cohort study
    Yan Xu, Yiding Zuo, Li Zhou, Xuechao Hao, Xiao Xiao, Mao Ye, Lulong Bo, Chunling Jiang, Jiayin Yang
    BMC Anesthesiology.2021;[Epub]     CrossRef
  • Can hepatocellular carcinoma recurrence be prevented after liver transplantation?
    Jong Man Kim
    Clinical and Molecular Hepatology.2021; 27(4): 562.     CrossRef
  • 13,246 View
  • 355 Download
  • 51 Web of Science
  • Crossref
Review

Liver development and regeneration

Clinical implications of advances in liver regeneration
Yong Jin Kwon, Kyeong Geun Lee, Dongho Choi
Clin Mol Hepatol 2015;21(1):7-13.
Published online March 25, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.1.7

Remarkable advances have been made recently in the area of liver regeneration. Even though liver regeneration after liver resection has been widely researched, new clinical applications have provided a better understanding of the process. Hepatic damage induces a process of regeneration that rarely occurs in normal undamaged liver. Many studies have concentrated on the mechanism of hepatocyte regeneration following liver damage. High mortality is usual in patients with terminal liver failure. Patients die when the regenerative process is unable to balance loss due to liver damage. During disease progression, cellular adaptations take place and the organ microenvironment changes. Portal vein embolization and the associating liver partition and portal vein ligation for staged hepatectomy are relatively recent techniques exploiting the remarkable progress in understanding liver regeneration. Living donor liver transplantation is one of the most significant clinical outcomes of research on liver regeneration. Another major clinical field involving liver regeneration is cell therapy using adult stem cells. The aim of this article is to provide an outline of the clinical approaches being undertaken to examine regeneration in liver diseases.

Citations

Citations to this article as recorded by  Crossref logo
  • Human umbilical cord mesenchymal stem cells enhance liver regeneration and decrease collagen content in fibrosis mice after partial hepatectomy by activating Wnt/β-catenin signaling
    Xuewei Li, Jinghui Feng, Haiqin Cheng, Ning Jin, Shanshan Jin, Zhizhen Liu, Jun Xu, Jun Xie
    Acta Biochimica et Biophysica Sinica.2025; 57(4): 604.     CrossRef
  • From Cells to Exosomes: a Review of Non-Surgical Biotherapeutic-Based Strategies for Liver Regeneration in the Face of End-Stage Diseases
    Fatemeh Askari Yazdian, Matin Mojaveri Samak, Amirhossein Larijani, Mohammad Taghi Ashoobi, Mohadese Kharaqani, Mohammad Amin Ghezel, Zahra Barabadi, Elham Vojoudi
    Stem Cell Reviews and Reports.2025; 21(6): 1669.     CrossRef
  • Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations
    Qi Liu, Senyan Wang, Jing Fu, Yao Chen, Jing Xu, Wenjuan Wei, Hao Song, Xiaofang Zhao, Hongyang Wang
    Clinical and Translational Medicine.2024;[Epub]     CrossRef
  • Interleukin‐33 facilitates liver regeneration through serotonin‐involved gut‐liver axis
    Yankai Wen, Christoph Emontzpohl, Long Xu, Constance L. Atkins, Jong‐Min Jeong, Yang Yang, Kangho Kim, Chuan Wu, Shizuo Akira, Cynthia Ju
    Hepatology.2023; 77(5): 1580.     CrossRef
  • Liver Regeneration-Related Genes of Nontumor Liver Tissues Predict the Prognosis of Patients with Hepatocellular Carcinoma
    Yanchao Xu, Yunzheng Li, Yanjun Lu, Weihong Wang, Zhaowu Lian, Zijie Wu, Binghua Li, Decai Yu
    Journal of Hepatocellular Carcinoma.2023; Volume 10: 2197.     CrossRef
  • Clinical Application of Regenerative Medicine in the Treatment of End-Stage Liver Diseases
    洪 刘
    Advances in Clinical Medicine.2022; 12(08): 7256.     CrossRef
  • Predicting liver regeneration following major resection
    Karolin Dehlke, Linda Krause, Silvana Tyufekchieva, Anastasia Murtha-Lemekhova, Philipp Mayer, Artyom Vlasov, Ursula Klingmüller, Nikola S. Mueller, Katrin Hoffmann
    Scientific Reports.2022;[Epub]     CrossRef
  • Comparing various scoring systems in the treatment of hepatocellular carcinoma with ALPPS
    Yan Xu, Xiaoling Hu, Jiangbin Li, Rui Dong
    International Journal of Surgery: Global Health.2021; 4(2): e44.     CrossRef
  • Establishing a 3D In Vitro Hepatic Model Mimicking Physiologically Relevant to In Vivo State
    Hyun Kyoung Kang, Madina Sarsenova, Da-Hyun Kim, Min Soo Kim, Jin Young Lee, Eun-Ah Sung, Myung Geun Kook, Nam Gyo Kim, Soon Won Choi, Vyacheslav Ogay, Kyung-Sun Kang
    Cells.2021; 10(5): 1268.     CrossRef
  • Astragaloside IV Suppresses Hepatic Proliferation in Regenerating Rat Liver after 70% Partial Hepatectomy via Down-Regulation of Cell Cycle Pathway and DNA Replication
    Gyeong-Seok Lee, Hee-Yeon Jeong, Hyeon-Gung Yang, Young-Ran Seo, Eui-Gil Jung, Yong-Seok Lee, Kung-Woo Nam, Wan-Jong Kim
    Molecules.2021; 26(10): 2895.     CrossRef
  • Geometrical model of lobular structure and its importance for the liver perfusion analysis
    Eduard Rohan, Jana Camprová Turjanicová, Václav Liška, Adélia Sequeira
    PLOS ONE.2021; 16(12): e0260068.     CrossRef
  • Small-molecule-mediated reprogramming: a silver lining for regenerative medicine
    Yohan Kim, Jaemin Jeong, Dongho Choi
    Experimental & Molecular Medicine.2020; 52(2): 213.     CrossRef
  • Extent of liver resection is associated with incomplete liver restoration and splenomegaly a long period after liver resection
    Nguyen Hai Nam, Kojiro Taura, Yusuke Kimura, Yusuke Uemoto, Kenji Yoshino, Ken Fukumitsu, Takamichi Ishii, Satoru Seo, Keiko Iwaisako, Shinji Uemoto
    Surgery.2020; 168(1): 40.     CrossRef
  • Directly induced hepatogenic cells derived from human fibroblast ameliorate liver fibrosis
    Ja Sung Choi, Seongho Han, Hyun Aae Ryu, Sung‐Whan Kim
    Journal of Tissue Engineering and Regenerative Medicine.2020; 14(8): 1028.     CrossRef
  • CDK5RAP3 Deficiency Restrains Liver Regeneration after Partial Hepatectomy Triggering Endoplasmic Reticulum Stress
    Shuchun Yang, Rui Yang, Huanmin Wang, Yue Huang, Yuyan Jia
    The American Journal of Pathology.2020; 190(12): 2403.     CrossRef
  • Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells
    Yohan Kim, Kyojin Kang, Seung Bum Lee, Daekwan Seo, Sangtae Yoon, Sung Joo Kim, Kiseok Jang, Yun Kyung Jung, Kyeong Geun Lee, Valentina M. Factor, Jaemin Jeong, Dongho Choi
    Journal of Hepatology.2019; 70(1): 97.     CrossRef
  • The role of extracellular matrix on liver stem cell fate: A dynamic relationship in health and disease
    Natalia Sánchez-Romero, Pilar Sainz-Arnal, Iris Pla-Palacín, Pablo Royo Dachary, Helen Almeida, Cristina Pastor, Daniela Rubio Soto, Milagros Chico Rodriguez, Emma Olmedo Arbizu, Lourdes Bengochea Martinez, Trinidad Serrano-Aulló, Pedro M. Baptista
    Differentiation.2019; 106: 49.     CrossRef
  • CD11b+Ly6G+ myeloid‐derived suppressor cells promote liver regeneration in a murine model of major hepatectomy
    Ido Nachmany, Yoel Bogoch, Ayelet Sivan, Omer Amar, Ekaterina Bondar, Nitzan Zohar, Oran Yakubovsky, Ofer Fainaru, Joseph M. Klausner, Niv Pencovich
    The FASEB Journal.2019; 33(5): 5967.     CrossRef
  • Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis
    Juan Li, Ying-Ren Zhao, Zhen Tian
    World Journal of Hepatology.2019; 11(5): 412.     CrossRef
  • Mesenchymal Stem Cells for Liver Regeneration in Liver Failure: From Experimental Models to Clinical Trials
    Maria P. de Miguel, I. Prieto, A. Moratilla, J. Arias, M. A. Aller
    Stem Cells International.2019; 2019: 1.     CrossRef
  • Generation of functional human hepatocytes in vitro: current status and future prospects
    Tomoko Yamaguchi, Juntaro Matsuzaki, Takeshi Katsuda, Yoshimasa Saito, Hidetsugu Saito, Takahiro Ochiya
    Inflammation and Regeneration.2019;[Epub]     CrossRef
  • Beneficial and Deleterious Effects of Female Sex Hormones, Oral Contraceptives, and Phytoestrogens by Immunomodulation on the Liver
    Luis E. Soria-Jasso, Raquel Cariño-Cortés, Víctor Manuel Muñoz-Pérez, Elizabeth Pérez-Hernández, Nury Pérez-Hernández, Eduardo Fernández-Martínez
    International Journal of Molecular Sciences.2019; 20(19): 4694.     CrossRef
  • Severe polycystic liver diseases: hepatectomy or waiting for liver transplantation?
    Zeyu Zhang, Kuan Hu, Jiajin Yang, Yufan Zhou, Zhiming Wang, Yun Huang
    Medicine.2019; 98(49): e18176.     CrossRef
  • Progress and prospects of circular RNAs in Hepatocellular carcinoma: Novel insights into their function
    Ji Hu, Peng Li, Yang Song, Yun‐xuan Ge, Xiao‐ming Meng, Cheng Huang, Jun Li, Tao Xu
    Journal of Cellular Physiology.2018; 233(6): 4408.     CrossRef
  • Three-Dimensional Bioprinting of Hepatic Structures with Directly Converted Hepatocyte-Like Cells
    Kyojin Kang, Yohan Kim, Hyeryeon Jeon, Seung Bum Lee, Ji Sook Kim, Su A Park, Wan Doo Kim, Heung Mo Yang, Sung Joo Kim, Jaemin Jeong, Dongho Choi
    Tissue Engineering Part A.2018; 24(7-8): 576.     CrossRef
  • Shaping the future of liver surgery
    D. Pereyra, P. Starlinger
    European Surgery.2018; 50(3): 132.     CrossRef
  • The multiple functions of melatonin in regenerative medicine
    Maryam Majidinia, Russel J. Reiter, Seyed Kazem Shakouri, Iraj Mohebbi, Mojgan Rastegar, Mojtaba Kaviani, Saber Ghazizadeh Darband, Rana Jahanban-Esfahlan, Seyed Mohammad Nabavi, Bahman Yousefi
    Ageing Research Reviews.2018; 45: 33.     CrossRef
  • Associating liver partition and portal vein ligation versus 2-stage hepatectomy
    Yi-Nan Shen, Cheng-Xiang Guo, Lin-Yan Wang, Yao Pan, Yi-Wen Chen, Xue-Li Bai, Ting-Bo Liang
    Medicine.2018; 97(35): e12082.     CrossRef
  • Portal venous velocity affects liver regeneration after right lobe living donor hepatectomy
    Chen-Tai Hou, Yao-Li Chen, Chia-Cheng Lin, Chen-Te Chou, Kuo-Hua Lin, Ping-Yi Lin, Ya-Lan Hsu, Chia-Bang Chen, Hui-Chuan Lin, Chih-Jan Ko, Su-Han Wang, Li-Chueh Weng, Chia-En Hsieh, Gianfranco D. Alpini
    PLOS ONE.2018; 13(9): e0204163.     CrossRef
  • Nonintegrating Direct Conversion Using mRNA into Hepatocyte-Like Cells
    Sangtae Yoon, Kyojin Kang, Young-duck Cho, Yohan Kim, Elina Maria Buisson, Ji-Hye Yim, Seung Bum Lee, Ki-Young Ryu, Jaemin Jeong, Dongho Choi
    BioMed Research International.2018; 2018: 1.     CrossRef
  • Deficiency of apoptosis-stimulating protein two of p53 promotes liver regeneration in mice by activating mammalian target of rapamycin
    Hongbo Shi, Yizhi Zhang, Jing Ji, Ping Xu, Honglin Shi, Xiujuan Yue, Feng Ren, Yu Chen, Zhongping Duan, Dexi Chen
    Scientific Reports.2018;[Epub]     CrossRef
  • Low-Power Laser Irradiation (LPLI): A Clinical Point of View on a Promising Strategy to Improve Liver Regeneration
    Tiago Gomes Araújo, Alexandre Gabarra Oliveira, Antonio R. Franchi Teixeira
    Journal of Lasers in Medical Sciences.2018; 9(4): 223.     CrossRef
  • Stereological analysis of size and density of hepatocytes in the porcine liver
    Khan L. Junatas, Zbyněk Tonar, Tereza Kubíková, Václav Liška, Richard Pálek, Patrik Mik, Milena Králíčková, Kirsti Witter
    Journal of Anatomy.2017; 230(4): 575.     CrossRef
  • Cellular Mechanisms of Liver Regeneration and Cell-Based Therapies of Liver Diseases
    Irina V. Kholodenko, Konstantin N. Yarygin
    BioMed Research International.2017; 2017: 1.     CrossRef
  • Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy
    Fernando Ezquer, Javiera Bahamonde, Ya-Lin Huang, Marcelo Ezquer
    Stem Cell Research & Therapy.2017;[Epub]     CrossRef
  • Generation of Multilayered 3D Structures of HepG2 Cells Using a Bio-printing Technique
    Hyeryeon Jeon, Kyojin Kang, Su A Park, Wan Doo Kim, Seung Sam Paik, Sang-Hun Lee, Jaemin Jeong, Dongho Choi
    Gut and Liver.2017; 11(1): 121.     CrossRef
  • Three-dimensional (3D) printing of mouse primary hepatocytes to generate 3D hepatic structure
    Yohan Kim, Kyojin Kang, Jaemin Jeong, Seung Sam Paik, Ji Sook Kim, Su A Park, Wan Doo Kim, Jisun Park, Dongho Choi
    Annals of Surgical Treatment and Research.2017; 92(2): 67.     CrossRef
  • Fabrication and evaluation of SDF-1 loaded galactosylated chitosan nanoparticles for liver targeting
    Chu Xue-Hui, Feng Zhang-Qi, Xu Qian, Xiao Jiang-Qiang, Yuan Xian-Wen, Sun Xi-Tai
    Materials Research Express.2017; 4(3): 035028.     CrossRef
  • Establishment of Hepatocellular Cancer Induced Pluripotent Stem Cells Using a Reprogramming Technique
    Han Joon Kim, Jaemin Jeong, Sunhoo Park, Young-Woo Jin, Seung-Sook Lee, Seung Bum Lee, Dongho Choi
    Gut and Liver.2017; 11(2): 261.     CrossRef
  • A phase I study on stereotactic body radiotherapy of liver metastases based on functional treatment planning using positron emission tomography with 2-[18F]fluoro-2-deoxy-d-galactose
    Mette Marie Fode, Kirstine Bak-Fredslund, Jørgen Baltzer Petersen, Esben Worm, Michael Sørensen, Morten Høyer
    Acta Oncologica.2017; 56(11): 1614.     CrossRef
  • Expression of hypoxia inducible factor-1α and its correlation with phosphoenolpyruvate carboxykinase after portal vein ligation in rats
    Changjun Jia, Hua Yang, Chaoliu Dai, Feng Xu, Songlin Peng, Yang Zhao, Chuang Zhao, Liang Zhao
    Life Sciences.2017; 190: 97.     CrossRef
  • MicroRNA-21 Contributes to Liver Regeneration by Targeting PTEN
    Xiaoyu Chen, Meiyi Song, Wei Chen, Jasmina Dimitrova-Shumkovska, Yingying Zhao, Yan Cao, Yang Song, Wenzhuo Yang, Fei Wang, Yang Xiang, Changqing Yang
    Medical Science Monitor.2016; 22: 83.     CrossRef
  • The Role of IL-1 Family Members and Kupffer Cells in Liver Regeneration
    Quanhui Tan, Jianjun Hu, Xiaolan Yu, Wen Guan, Huili Lu, Yan Yu, Yongsheng Yu, Guoqiang Zang, Zhenghao Tang
    BioMed Research International.2016; 2016: 1.     CrossRef
  • An updated systematic review of the evolution of ALPPS and evaluation of its advantages and disadvantages in accordance with current evidence
    Yu-Long Cai, Pei-Pei Song, Wei Tang, Nan-Sheng Cheng
    Medicine.2016; 95(24): e3941.     CrossRef
  • Prediction of postoperative liver regeneration from clinical information using a data-led mathematical model
    Kimiyo N. Yamamoto, Masatsugu Ishii, Yoshihiro Inoue, Fumitoshi Hirokawa, Ben D. MacArthur, Akira Nakamura, Hiroshi Haeno, Kazuhisa Uchiyama
    Scientific Reports.2016;[Epub]     CrossRef
  • Functional comparison of human embryonic stem cells and induced pluripotent stem cells as sources of hepatocyte-like cells
    Jaemin Jeong, Kyu Nam Kim, Min Sung Chung, Han Joon Kim
    Tissue Engineering and Regenerative Medicine.2016; 13(6): 740.     CrossRef
  • 16,674 View
  • 229 Download
  • 52 Web of Science
  • Crossref